These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 28932036)

  • 21. The pathophysiological significance of nondesmoglein targets of pemphigus autoimmunity. Development of antibodies against keratinocyte cholinergic receptors in patients with pemphigus vulgaris and pemphigus foliaceus.
    Vu TN; Lee TX; Ndoye A; Shultz LD; Pittelkow MR; Dahl MV; Lynch PJ; Grando SA
    Arch Dermatol; 1998 Aug; 134(8):971-80. PubMed ID: 9722727
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clues to diagnosis for unusual mucosal pemphigus demonstrating undetectable anti-desmoglein 3 serum antibodies by routine tests.
    Kamiya K; Aoyama Y; Yamaguchi M; Ukida A; Mizuno-Ikeda K; Fujii K; Hamada T; Tokura Y; Iwatsuki K
    J Dermatol; 2015 Jun; 42(6):572-9. PubMed ID: 25832452
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alteration of cholinergic system in keratinocytes cells produces acantholysis: a possible use of cholinergic drugs in pemphigus vulgaris.
    Fania L; Zampetti A; Guerriero G; Feliciani C
    Antiinflamm Antiallergy Agents Med Chem; 2012; 11(3):238-42. PubMed ID: 23140385
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Possible apoptotic mechanism in epidermal cell acantholysis induced by pemphigus vulgaris autoimmunoglobulins.
    Wang X; Brégégère F; Frusić-Zlotkin M; Feinmesser M; Michel B; Milner Y
    Apoptosis; 2004 Mar; 9(2):131-43. PubMed ID: 15004510
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An immunohistological study of desmosomal components in pemphigus.
    Burge SM; Wilson CL; Dean D; Wojnarowska F
    Br J Dermatol; 1993 Apr; 128(4):363-70. PubMed ID: 8494748
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeted disruption of the pemphigus vulgaris antigen (desmoglein 3) gene in mice causes loss of keratinocyte cell adhesion with a phenotype similar to pemphigus vulgaris.
    Koch PJ; Mahoney MG; Ishikawa H; Pulkkinen L; Uitto J; Shultz L; Murphy GF; Whitaker-Menezes D; Stanley JR
    J Cell Biol; 1997 Jun; 137(5):1091-102. PubMed ID: 9166409
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunolocalization of desmoglein I ("band 3" polypeptide) on acantholytic cells in pemphigus vulgaris, Darier's disease, and Hailey-Hailey's disease.
    Setoyama M; Hashimoto K; Tashiro M
    J Dermatol; 1991 Sep; 18(9):500-5. PubMed ID: 1787220
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Apoptotic pathways in the pathogenesis of pemphigus: targets for new therapies.
    Lotti R; Marconi A; Pincelli C
    Curr Pharm Biotechnol; 2012 Aug; 13(10):1877-81. PubMed ID: 22250711
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The molecular logic of pemphigus and impetigo: the desmoglein story.
    Amagai M
    Vet Dermatol; 2009 Oct; 20(5-6):308-12. PubMed ID: 20178466
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The location of binding sites of pemphigus vulgaris and pemphigus foliaceus autoantibodies: a post-embedding immunoelectron microscopic study.
    Zhou S; Ferguson DJ; Allen J; Wojnarowska F
    Br J Dermatol; 1997 Jun; 136(6):878-83. PubMed ID: 9217820
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral pemphigus.
    Giannetti L; Generali L; Bertoldi C
    G Ital Dermatol Venereol; 2018 Jun; 153(3):383-388. PubMed ID: 29512980
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acantholysis and spongiosis are associated with loss of syndecan-1 expression.
    Bayer-Garner I; Dilday B; Sanderson R; Smoller B
    J Cutan Pathol; 2001 Mar; 28(3):135-9. PubMed ID: 11168765
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The pathogenesis of bullous skin diseases.
    Yang M; Wu H; Zhao M; Chang C; Lu Q
    J Transl Autoimmun; 2019 Dec; 2():100014. PubMed ID: 32743502
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pemphigus chronicus vulgaris--case report].
    Spoljar S; Cavka M; Tvorić A
    Acta Med Croatica; 2012 Oct; 66 Suppl 1():41-7. PubMed ID: 23193820
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Soluble Fas Ligand Is Essential for Blister Formation in Pemphigus.
    Lotti R; Shu E; Petrachi T; Marconi A; Palazzo E; Quadri M; Lin A; O'Reilly LA; Pincelli C
    Front Immunol; 2018; 9():370. PubMed ID: 29535737
    [TBL] [Abstract][Full Text] [Related]  

  • 36. If pemphigus vulgaris IgG are the cause of acantholysis, new IgG-independent mechanisms are the concause.
    Cirillo N; Lanza M; Femiano F; Gaeta GM; De Rosa A; Gombos F; Lanza A
    J Cell Physiol; 2007 Sep; 212(3):563-7. PubMed ID: 17474087
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pemphigus].
    Callot V; Bagot M
    Rev Prat; 1994 Jan; 44(1):81-5. PubMed ID: 8178064
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Focal adhesion kinase is expressed in acantholytic keratinocytes associated with pemphigus vulgaris and pemphigus foliaceus.
    Penneys NS
    Br J Dermatol; 1996 Oct; 135(4):592-4. PubMed ID: 8915152
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protease inhibitors prevent plasminogen-mediated, but not pemphigus vulgaris-induced, acantholysis in human epidermis.
    Schuh T; Besch R; Braungart E; Flaig MJ; Douwes K; Sander CA; Magdolen V; Probst C; Wosikowski K; Degitz K
    Biol Chem; 2003 Feb; 384(2):311-5. PubMed ID: 12675525
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.